We have recently reported that InsP5 is a novel inhibitor of the PI3K/Akt pathway, which possesses pro-apoptotic, anti-angiogenic and anti-tumour activity (Razzini et al, 2000; Piccolo et al, 2004; Maffucci et al, 2005). Here, AKT1 is linked to neoplasm.